Physician profile
Elise L Beatty
NPI 1942287511
$552.95
in general payments reported to CMS, 2019-2025
11 companies · $33.99 in 2025
The $33.99 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $36.38 · 2020: $72.01 · 2021: $103 · 2022: $192 · 2023: $39.53 · 2024: $76.31 · 2025: $33.99.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $149.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $143.23 | 2022-2025 | Total30, Rocklatan |
| Allergan, INC. | $110.44 | 2020-2021 | |
| Sun Pharmaceutical Industries INC. | $86.92 | 2022 | |
| Abbvie INC. | $65.47 | 2022-2025 | Lumigan |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $33.08 | 2019-2021 | |
| Harrow Eye, LLC | $24.49 | 2024 | Triesence, Iheezo |
| Johnson & Johnson Surgical Vision, INC. | $21.68 | 2024 | Tecnis Simplicity |
| Kala Pharmaceuticals, INC. | $20.25 | 2021 | |
| Aerie Pharmaceuticals, INC. | $16.19 | 2021 | |
| Sight Sciences, INC. | $16.05 | 2019 | |
| Biotissue Holdings INC. | $15.15 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elise Beatty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.